AIG
AMLX icon

American International Group’s Amylyx Pharmaceuticals AMLX Stock Holding History

American International Group’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-25,031
Closed -$71.1K – 144
2024
Q1 		$71.1K Sell
25,031
-215
-0.9% -$2.81K ﹤0.01% 2681
2023
Q4 		$372K Sell
25,246
-102
-0.4% -$1.56K ﹤0.01% 1827
2023
Q3 		$464K Buy
25,348
+901
+4% +$19.1K ﹤0.01% 1649
2023
Q2 		$527K Buy
24,447
+109
+0.4% +$2.94K ﹤0.01% 1607
2023
Q1 		$714K Buy
24,338
+485
+2% +$16.8K ﹤0.01% 1412
2022
Q4 		$881K Buy
23,853
+7,117
+43% +$253K 0.01% 1269
2022
Q3 		$471K Buy
16,736
+11,368
+212% +$284K ﹤0.01% 1617
2022
Q2 		$103K Buy
5,368
+608
+13% +$7.22K ﹤0.01% 2583
2022
Q1 		$61K Buy
+4,760
New +$108K ﹤0.01% 2773

Other funds holding AMLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

American International Group's AMLX Position: Q2 2024 in Review

American International Group sold out of Amylyx Pharmaceuticals (AMLX) in Q2 2024, closing a stake of 25,031 shares — an estimated $71.1K sold.

American International Group first reported a position in AMLX in Q1 2022 and held it in 9 quarters. The position peaked at $881K in Q4 2022. 119 funds tracked by Wall St. Rank hold AMLX as of Q2 2024.

  • American International Group reported no remaining Amylyx Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 25,031 Amylyx Pharmaceuticals shares in Q2 2024, an estimated $71.1K.
  • American International Group first reported a position in Amylyx Pharmaceuticals in Q1 2022 and held it in 9 quarters.
  • American International Group's Amylyx Pharmaceuticals position peaked at $881K in Q4 2022.
  • 119 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.